Karimah Es Sabar
Ms. Es Sabar is CEO and Partner at Quark Venture Inc., a venture capital investment firm. She most recently led The Centre for Drug Research and Development (CDRD) as President and CEO. Karimah Es Sabar has 30 years of dynamic global business experience. She previously led LifeSciences BC, a strong business development organization for the life science industry and the scientific research community. She has also held senior management positions with international multinational companies, most notably Connaught Laboratories Limited [Sanofi Pasteur], as well as start-ups such as Medsurge Medical Inc., and SAL Healthcare Limited, a leading pharmaceutical marketing, distribution and healthcare consulting services firm which she founded.
In 2013, Ms. Es Sabar was appointed Founding Chair of the Global Alliance of Leading Drug Discovery and Development Centres, an association of international peer organizations dedicated to translating health research into new medicines; and has served on the Boards of a number of organizations, including the Providence Healthcare Research Institute (which she currently chairs), the Prostate Centre Advisory Board, Vancouver General Hospital); NRC Council, NRC – IRAP Advisory Board; and is also Past-President of MOSAIC, a non-profit organization dedicated to addressing issues that affect immigrants and refugees in the course of their settlement and integration into Canadian society.
Ms. Es Sabar has been the recipient of a number of awards and recognitions including Canada's Gold Award for Business Excellence (CABE) while at Sanofi Pasteur; and the Women's Executive Network's "2013 Canada's Most Powerful Women: Top 100 Award." Ms. Es Sabar holds a B.Sc. (joint honours) in biochemistry/chemistry from the University of Salford, a M.Sc. in neurochemistry from the University of London, and an Executive Certificate in Management and Leadership from MIT Sloan School of Management.
Ms. Es Sabar was appointed to Council in May 2014.
- Date modified: